Jacob Mercer's Colleagues at QED Therapeutics
Jacob Mercer's Contact Details
HQ
650-231-4088
650-231-4088
Location
Company
QED Therapeutics
QED Therapeutics
Jacob Mercer's Company Details
QED Therapeutics, a subsidiary of BridgeBio Pharma, is a biotechnology company focused on precision medicine for FGFR-driven disorders. Our lead candidate is infigratinib, a best-in-class FGFR kinase inhibitor that has shown meaningful clinical activity in chemotherapy-refractory cholangiocarcinoma with FGFR2 fusions. QED is also evaluating infigratinib in preclinical studies for the treatment of achondroplasia. We plan to develop infigratinib in additional FGFR-driven tumor types and rare disorders.
Frequently Asked Questions about Jacob Mercer
Jacob Mercer currently works for QED Therapeutics.
Jacob Mercer's role at QED Therapeutics is Medical Science Liaison, Oncology.
Jacob Mercer's email address is ***@qedtx.com. To view Jacob Mercer's full email address, please signup to ConnectPlex.
Jacob Mercer works in the Biotechnology industry.
Jacob Mercer's colleagues at QED Therapeutics are Liz Bergan, Brett Kuenne, Vermali Rodriguez, Kathleen Guindon, Brian Boyles, Richard Jones II, Edward Oliva and others.
Jacob Mercer's phone number is 650-231-4088